礼来(LLY)最主要的收入来源是什么？

通过最新财报数据拆解，该公司的收入主要由其核心业务板块与相关服务支持构成。您可以通过页面上的交互式图表直观查看各业务线对总营收的具体贡献比例。

如何直观分析 LLY 的财务状况与盈利模式？

瓜壳日历通过交互式桑基图(Sankey Diagram)和瀑布图(Waterfall Chart)，将该公司的总营收、销售成本、运营费用以及最终的净利润流程进行了全景可视化，方便投资者一分钟看懂其经营效率与现金流走向。

Income Statement Q1 2026
Item	Category	Value	YoY
Revenue	revenue	19.80B	55.54%
Income before income taxes	profit	8.85B	156.08%
Costs, expenses, and other	cost	10.95B	18.07%
Net income	profit	7.40B	168.07%
Income taxes	cost	1.45B	108.61%
Cost of sales	cost	3.58B	60.76%
Research and development	cost	3.51B	28.38%
Marketing, selling, and administrative	cost	2.93B	18.88%
Acquired in-process research and development	cost	584.00M	-62.85%
Asset impairment, restructuring, and other special charges	cost	279.00M	697.14%
Nonoperating income (expense)	revenue	65.00M	-72.80%

Geography Breakdown
Segment	Value	YoY
UNITED STATES	12.12B	42.76%
Non-US	7.68B	81.17%

Products Breakdown
Segment	Value	YoY
Mounjaro	8.66B	125.46%
Zepbound	4.16B	79.93%
Verzenio	1.30B	12.34%
Jardiance	1.11B	9.86%
Other Oncology	966.00M	22.43%
Trulicity	919.00M	-16.07%
Other Cardiometabolic Health	905.00M	-4.23%
Taltz	733.00M	-3.81%
Other Immunology	470.00M	44.17%
Neuroscience	382.00M	40.44%
Product and Service, Other	187.00M	-12.21%

Balance Sheet Q1 2026
Item	Category	Value
Accounts receivable	assets	18.43B
Inventories	assets	14.53B
Prepaid expenses	assets	13.63B
Cash and cash equivalent	assets	5.28B
Other receivables	assets	2.75B
Other current assets	assets	214.00M
Total current assets	assets	54.84B
Property and equipment, net	assets	26.54B
Deferred income tax assets, net	assets	11.35B
Other intangibles, net	assets	7.37B
Other noncurrent assets	assets	7.23B
Goodwill	assets	6.13B
Investments	assets	3.12B
Total assets	assets	116.58B
Total noncurrent liabilities	liabilities	48.74B
Total current liabilities	liabilities	36.63B
Total equity	equity	31.20B
Common stock, shares held in employee trust	equity	3.01B
Accumulated other comprehensive loss	equity	2.83B
Long-term debt	liabilities	39.37B
Long-term income taxes payable	liabilities	5.29B
Other noncurrent liabilities	liabilities	4.08B
Sales rebates and discounts	liabilities	17.55B
Other current liabilities	liabilities	8.70B
Accounts payable	liabilities	5.03B
Short-term borrowings and current maturities of long-term debt	liabilities	4.00B
Employee compensation	liabilities	1.36B
Aggregate	equity	37.04B
Retained earnings	equity	29.51B
Additional paid-in capital	equity	6.92B
Common stock	equity	590.00M
Other additional capital	equity	19.00M

Operating Activities – 3M 2026
Item	Value
Net income	7.40B
Acquired in-process research and development	584.00M
Depreciation and amortization	509.00M
Stock-based compensation expense	161.00M
Other operating activities, net	-175.00M
Increase (decrease) in deferred income taxes	-1.48B
Increase (decrease) in other operating assets and liabilities, net	-1.66B

Investing Activities – 3M 2026
Item	Value
Payment for (proceeds from) other investing activity	-31.00M
Payments to acquire in process research and development	-204.00M
Payments to acquire other investments	-297.00M
Other payments to acquire businesses	-1.06B
Payments to acquire other property, plant, and equipment	-2.33B

Financing Activities – 3M 2026
Item	Value
Net change in short-term borrowings	1.77B
Other financing activities, net	-591.00M
Repayments of long-term debt	-750.00M
Payments of dividends	-1.55B
Payments for repurchase of common stock	-2.36B

Cash Balance – 3M 2026
Item	Value
Cash and cash equivalents, beginning of period	7.27B
Cash and cash equivalents, end of period	5.28B